MK-677 (Ibutamoren)
Oral GH secretagogue — stimulates GH and IGF-1 without injection.
What Is MK-677 (Ibutamoren)?
MK-677 (Ibutamoren) is a non-peptide oral GH secretagogue that mimics ghrelin and activates the GH secretagogue receptor (GHSR). Unlike injectable GH peptides, MK-677 is taken orally and provides sustained GH and IGF-1 elevation. It is studied for body composition, bone density, and anti-aging benefits.
🔬 Mechanism of Action
MK-677 (ibutamoren) is a non-peptide, orally active ghrelin receptor (GHSR-1a) agonist that stimulates pituitary GH secretion by mimicking the action of endogenous ghrelin. Unlike injectable GH secretagogue peptides, MK-677 is metabolically stable to oral administration and has a half-life of approximately 24 hours, enabling once-daily oral dosing. It produces sustained elevations in both GH and IGF-1 without significantly affecting cortisol, and does not require injection, making it a widely studied secretagogue in clinical pharmacology.
Effectiveness Profile
Relative effectiveness scores derived from published preclinical literature across key endpoints.
Scores are qualitative aggregates from animal and in vitro studies and are not a medical claim. For educational purposes only.
Applications & Benefits
Key Study Findings
Demonstrated dose-dependent, sustained GH and IGF-1 elevation over 24 hours with oral administration in human pharmacokinetic studies
Clinical trials report increases in lean body mass and reductions in muscle wasting in elderly and calorie-restricted subjects
Shown to improve sleep quality metrics — specifically slow-wave sleep — in controlled studies, consistent with GH's role in sleep physiology
Investigated for bone mineral density support in aging cohorts over 12+ month periods
24-hour half-life supports single-dose daily protocols and stable steady-state GH levels
Effect Timeline
Expected milestones based on published preclinical data.
First amplified GH pulses detected. Slight IGF-1 elevation begins; anabolic signaling pathways activate.
IGF-1 levels plateau at elevated baseline. Protein synthesis increases; recovery from training improves noticeably.
Lean mass accumulation measurable. Fat oxidation increases; sleep quality improvements typically reported.
Maximum body composition improvements at sustained elevated GH/IGF-1 levels. Anti-aging mechanisms fully engaged.
First amplified GH pulses detected. Slight IGF-1 elevation begins; anabolic signaling pathways activate.
IGF-1 levels plateau at elevated baseline. Protein synthesis increases; recovery from training improves noticeably.
Lean mass accumulation measurable. Fat oxidation increases; sleep quality improvements typically reported.
Maximum body composition improvements at sustained elevated GH/IGF-1 levels. Anti-aging mechanisms fully engaged.
Timelines are derived from preclinical animal studies. Individual results in laboratory settings may vary. For educational purposes only.
Dosing Protocol
Dosing information is derived from published animal studies and is provided for educational purposes only.
Reconstitution Calculator
Calculate exact BAC water volume and dose measurements for MK-677 (Ibutamoren).
For laboratory use only. This calculator is a reference tool — verify all calculations before use. Always use sterile technique with bacteriostatic water and sterile syringes.
Synergistic Stack Combinations
Frequently Asked Questions
Is MK-677 a peptide?
MK-677 is not a peptide but rather a small-molecule, non-peptide ghrelin mimetic. Its chemical structure allows it to resist gastrointestinal degradation and hepatic first-pass metabolism, enabling reliable oral bioavailability. This distinguishes it from GH secretagogue peptides such as ipamorelin or sermorelin, which require injection to remain biologically active.
Why does MK-677 affect sleep in studies subjects?
Growth hormone secretion is closely linked to sleep architecture, particularly slow-wave (delta) sleep. MK-677 elevates GH secretion, and study subjects have demonstrated increased time in slow-wave sleep stages during MK-677 administration. This has made it a subject of interest in sleep quality and age-related sleep deterioration, where declining GH correlates with reduced slow-wave sleep.
What is the typical study duration for MK-677?
Studies have ranged from 8-week acute trials to 24-month extended trials, the latter primarily examining bone density and muscle mass outcomes in aging populations. The oral route and once-daily dosing make long-duration studies more practical than injectable peptides. IGF-1 is commonly used as a biomarker to confirm target engagement across study durations.
💎MK-677 (Ibutamoren) for Looksmaxxing
MK-677 is one of the most looksmaxxing-friendly peptides because of its oral convenience — no injections required for daily GH stimulation. In looksmaxxing body recomposition stacks it's used as a continuous daily background GH secretagogue, often combined with injectable CJC-1295 + Ipamorelin on training days. Its consistent IGF-1 elevation supports lean mass preservation during caloric restriction phases and promotes the sleep quality that drives GH-mediated recovery. The once-nightly oral dosing makes it practical for long 16–24 week looksmaxxing cycles.
Related Topics
MK-677
For educational use only · Verified vendor
